CASE REPORT
Pleural mesothelioma metastasis of the scalp
 
More details
Hide details
1
Department of Medical Pathology, Health Sciences University Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey
 
2
Dicle University Faculty of Medicine, Department of Medical Pathology, Diyarbakir, Turkey
 
 
Submission date: 2023-04-25
 
 
Final revision date: 2023-08-20
 
 
Acceptance date: 2023-08-30
 
 
Publication date: 2024-02-01
 
 
Pol J Pathol 2023;74(4):297-301
 
KEYWORDS
TOPICS
ABSTRACT
Mesothelioma is a locally aggressive malignant tumor that arises on the mesothelial surfaces of the pleura, peritoneum and tunica vaginalis. There are three histologic subtypes of mesothelioma: epithelioid, biphasic, and sarcomatoid. Pleural mesothelioma is usually characterized by diffuse pleural thickening. Disease progression is characterized by local invasion of the chest wall and lung. Lymphatic metastasis is rare and hematogenous metastasis is much rarer. The purpose of these case reports is to emphasize that pleural mesothelioma metastases can occur in unexpected places and to contribute to the literature.
REFERENCES (14)
1.
Alpert NM, van Gerwen, Taioli E. Epidemiology of mesothe- lioma in the 21(st) century in Europe and the United States, 40 years after restricted/banned asbestos use. Transl Lung Cancer Res 2020; 9: S28-s38.
 
2.
Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol 2009; 27: 2081-2090.
 
3.
Hajj GNM, Cavarson CH, Pinto CAP, et al. Malignant pleural mesothelioma: an update. J Bras Pneumol 2021; 47: e20210129.
 
4.
Metintaş S, Batirel HF, Bayram H, et al. Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program. Int J Environ Res Public Health 2017; 14: 1293.
 
5.
Sule Kutlar Dursun F, Alabalik U. Investigation of pd-l1 (cd274), pd-l2 (pdcd1lg2), and ctla-4 expressions in malignant pleural mesothelioma by immunohistochemistry and real-time polymerase chain reaction methods. Pol J Pathol 2022; 73: 111-119.
 
6.
Dacic S. Pleural mesothelioma classification-update and chal- lenges. Mod Pathol 2022; 35 (Suppl 1): 51-56.
 
7.
Quijano Moreno SL, García de Lacoba M. Metastasis of malig- nant pleural mesothelioma to the scalp following chemother- apy: a case report and review of the literature. Rev Esp Patol 2022; 55 Suppl 1: S27-s31.
 
8.
Kanbay A, Oguzulgen KI, Ozturk C, et al. Malignant pleu ral mesothelioma with scalp, cerebellar, and finger metastases: a rare case. South Med J 2007; 100: 63-65.
 
9.
Sauter JL, Dacic S, Galateau-Salle F, et al. The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification. J Thorac Oncol 2022; 17: 608-622.
 
10.
Bazex A, Miguères J, Dupré A, Christol B, Jover A, Cantala P. Métastases au niveau du cuir chevelu d'un mésonthéliome pleural [Scalp metastases of pleural mesothelioma]. Bull Soc Fr Dermatol Syphiligr 1969; 76: 99-101.
 
11.
Ward RE, Ali SA, Kuhar M. Epithelioid malignant mesothe- lioma metastatic to the skin: a case report and review of the literature. J Cutan Pathol 2017; 44: 1057-1063.
 
12.
Pulford E, Huilgol K, Moffat D, et al. Malignant mesothelioma, BAP1 immunohistochemistry, and VEGFA: does BAP1 have potential for early diagnosis and assessment of prognosis? Dis Markers 2017; 2017: 1310478.
 
13.
Brcic L, Le Stang N, Gallob F, et al. A Combination of MTAP and p16 immunohistochemistry can substitute for CDKN2A fluorescence in situ hybridization in diagnosis and prognosis of pleural mesotheliomas. Arch Pathol Lab Med 2023; 147: 313-322.
 
14.
Yetişkin İ, Kömürcüoğlu BE, Yıldırım E. Mezotelyoma’nın saçlı deri metastazı. İzmir Göğüs Hastanesi Dergisi 2021; 35: 109-112.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top